BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26859807)

  • 1. Determinants of High-Risk Human Papillomavirus Seroprevalence and DNA Prevalence in Mid-Adult Women.
    Sadate-Ngatchou P; Carter JJ; Hawes SE; Feng Q; Lasof T; Stern JE; Fu TC; Galloway DA; Koutsky LA; Winer RL
    Sex Transm Dis; 2016 Mar; 43(3):192-8. PubMed ID: 26859807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors for oncogenic human papillomavirus infections in high-risk mid-adult women.
    Winer RL; Hughes JP; Feng Q; Xi LF; Lee SK; O'Reilly SF; Kiviat NB; Koutsky LA
    Sex Transm Dis; 2012 Nov; 39(11):848-56. PubMed ID: 23064533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic Human Papillomavirus Infections in 18- to 24-Year-Old Female Online Daters.
    Barrere A; Stern JE; Feng Q; Hughes JP; Winer RL
    Sex Transm Dis; 2015 Sep; 42(9):492-7. PubMed ID: 26267875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study.
    Tay SK; Oon LL
    Int J STD AIDS; 2014 Dec; 25(14):1013-21. PubMed ID: 24648316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-detection vs. new acquisition of high-risk human papillomavirus in mid-adult women.
    Fu TC; Carter JJ; Hughes JP; Feng Q; Hawes SE; Schwartz SM; Xi LF; Lasof T; Stern JE; Galloway DA; Koutsky LA; Winer RL
    Int J Cancer; 2016 Nov; 139(10):2201-12. PubMed ID: 27448488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of genital HPV infections and HPV serology in adolescent girls, prior to vaccination.
    Mollers M; Scherpenisse M; van der Klis FR; King AJ; van Rossum TG; van Logchem EM; Feltkamp MC; Meijer CJ; Snijders PJ; Boot HJ; de Melker HE
    Cancer Epidemiol; 2012 Dec; 36(6):519-24. PubMed ID: 22906483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and determinants of high-risk human papillomavirus infection in women from a sub-Saharan African community.
    Sangwa-Lugoma G; Ramanakumar AV; Mahmud S; Liaras J; Kayembe PK; Tozin RR; Lorincz A; Franco EL
    Sex Transm Dis; 2011 Apr; 38(4):308-15. PubMed ID: 21150817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of seropositivity to multiple oncogenic human papillomavirus types among human immunodeficiency virus-positive and -negative Ugandan women.
    Namujju PB; Waterboer T; Banura C; Muwonge R; Mbidde EK; Byaruhanga R; Muwanga M; Surcel HM; Pawlita M; Lehtinen M
    J Gen Virol; 2011 Dec; 92(Pt 12):2776-2783. PubMed ID: 21832008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal and anal human papillomavirus infection and seropositivity among female sex workers in Amsterdam, the Netherlands: Prevalence, concordance and risk factors.
    Marra E; Kroone N; Freriks E; van Dam CL; Alberts CJ; Hogewoning AA; Bruisten S; van Dijk A; Kroone MM; Waterboer T; Schim van der Loeff MF
    J Infect; 2018 Apr; 76(4):393-405. PubMed ID: 29289562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of cervicovaginal human papillomavirus detection in perimenopausal women.
    Althoff KN; Paul P; Burke AE; Viscidi R; Sangaramoorthy M; Gravitt PE
    J Womens Health (Larchmt); 2009 Sep; 18(9):1341-6. PubMed ID: 19702476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
    Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
    Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of Human Papillomavirus Detected in the Oral Cavity and Fingernails of Mid-Adult Women.
    Fu TC; Hughes JP; Feng Q; Hulbert A; Hawes SE; Xi LF; Schwartz SM; Stern JE; Koutsky LA; Winer RL
    Sex Transm Dis; 2015 Dec; 42(12):677-85. PubMed ID: 26562696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for high-risk human papillomavirus detection among HIV-negative and HIV-positive women from Tanzania.
    Dartell M; Rasch V; Munk C; Kahesa C; Mwaiselage J; Iftner T; Kjaer SK
    Sex Transm Dis; 2013 Sep; 40(9):737-43. PubMed ID: 23949589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys.
    Vaccarella S; Herrero R; Snijders PJ; Dai M; Thomas JO; Hieu NT; Ferreccio C; Matos E; Posso H; de Sanjosé S; Shin HR; Sukvirach S; Lazcano-Ponce E; Muñoz N; Meijer CJ; Franceschi S;
    Int J Epidemiol; 2008 Jun; 37(3):536-46. PubMed ID: 18316350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence and Associated Factors of 9-Valent Human Papillomavirus (HPV) Types among Men in the Multinational HIM Study.
    Rahman S; Pierce Campbell CM; Rollison DE; Wang W; Waterboer T; Michel A; Pawlita M; Villa LL; Lazcano Ponce E; Borenstein AR; Giuliano AR
    PLoS One; 2016; 11(11):e0167173. PubMed ID: 27902759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal high-risk human papillomavirus infection in a cross-sectional study among women of six different ethnicities in Amsterdam, the Netherlands: the HELIUS study.
    Alberts CJ; Vos RA; Borgdorff H; Vermeulen W; van Bergen J; Bruisten SM; Geerlings SE; Snijder MB; van Houdt R; Morré SA; de Vries HJ; van de Wijgert JH; Prins M; Schim van der Loeff MF
    Sex Transm Infect; 2016 Dec; 92(8):611-618. PubMed ID: 27188273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group.
    Sellors JW; Mahony JB; Kaczorowski J; Lytwyn A; Bangura H; Chong S; Lorincz A; Dalby DM; Janjusevic V; Keller JL
    CMAJ; 2000 Sep; 163(5):503-8. PubMed ID: 11006760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys.
    Vaccarella S; Franceschi S; Herrero R; Muñoz N; Snijders PJ; Clifford GM; Smith JS; Lazcano-Ponce E; Sukvirach S; Shin HR; de Sanjosé S; Molano M; Matos E; Ferreccio C; Anh PT; Thomas JO; Meijer CJ;
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):326-33. PubMed ID: 16492924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, clearance and predictors of human papillomavirus infection in women.
    Sellors JW; Karwalajtys TL; Kaczorowski J; Mahony JB; Lytwyn A; Chong S; Sparrow J; Lorincz A;
    CMAJ; 2003 Feb; 168(4):421-5. PubMed ID: 12591782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk factors for genital high-risk human papillomavirus infection among women attending the out-patient clinics of a university teaching hospital in Lagos, Nigeria.
    Okunade KS; Nwogu CM; Oluwole AA; Anorlu RI
    Pan Afr Med J; 2017; 28():227. PubMed ID: 29629013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.